Lataa...
Two Antagonistic Microtubule Targeting Drugs Act Synergistically to Kill Cancer Cells
Paclitaxel is a microtubule stabilizing agent and a successful drug for cancer chemotherapy inducing, however, adverse effects. To reduce the effective dose of paclitaxel, we searched for pharmaceutics which could potentiate its therapeutic effect. We screened a chemical library and selected Carba1,...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7463452/ https://ncbi.nlm.nih.gov/pubmed/32781579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082196 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|